Michael E. Hurwitz
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 18
- CAR-T cell therapy research 9
-
- Renal cell carcinoma treatment 10
- Prostate Cancer Treatment and Research 6
- Prostate Cancer Diagnosis and Treatment 3
- Co-authors
- Harriet M. Kluger (15 shared papers)Bryden Considine (4 shared papers)Howard Robert Horvitz (4 shared papers)Mario Sznol (5 shared papers)Caterina Strambio‐De‐Castillia (1 shared paper)Laird Bloom (3 shared papers)Günter Blobel (1 shared paper)Pamela J. Vanderzalm (3 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (7 papers)Cancer Discovery (4 papers)Current Oncology Reports (3 papers)Clinical Genitourinary Cancer (3 papers)The American Journal of Surgery (3 papers)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Michael E. Hurwitz
66 papers receiving 3.5k citations
Michael E. Hurwitz's Hit Papers
Peers
Comparison fields: 5 of 106
- Pulmonary and Respiratory Medicine 1.7k
- Oncology 1.1k
- Immunology 596
- Aging 46
- Cancer Research 272
Countries citing papers authored by Michael E. Hurwitz
This map shows the geographic impact of Michael E. Hurwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Hurwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Hurwitz more than expected).
Fields of papers citing papers by Michael E. Hurwitz
This network shows the impact of papers produced by Michael E. Hurwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Hurwitz. The network helps show where Michael E. Hurwitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Hurwitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2019 | 1263 |
| 2 | Prostate Cancer, Version 1.2016 Hit paper breakdown → | 2016 | 568 |
| 3 | 2020 | 210 | |
| 4 | 2019 | 202 | |
| 5 | 2020 | 150 | |
| 6 | CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2024 | 116 |
| 7 | 2021 | 89 | |
| 8 | 2020 | 78 | |
| 9 | 2021 | 67 | |
| 10 | 2022 | 61 | |
| 11 | 2023 | 58 | |
| 12 | 1998 | 53 | |
| 13 | 1994 | 48 | |
| 14 | 2009 | 41 | |
| 15 | 2019 | 41 | |
| 16 | 2019 | 40 | |
| 17 | 2009 | 37 | |
| 18 | 2009 | 32 | |
| 19 | 2015 | 25 | |
| 20 | 2023 | 25 |
About Michael E. Hurwitz
Michael E. Hurwitz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Gender Studies and Radiology, Nuclear Medicine and Imaging, having authored 68 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Renal cell carcinoma treatment (10 papers), CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (6 papers), Prostate Cancer Treatment and Research (6 papers), Higher Education Research Studies (5 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.7k citations), Oncology (1.1k citations), Immunology (596 citations), Aging (46 citations) and Cancer Research (272 citations). Michael E. Hurwitz has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Harriet M. Kluger, Bryden Considine, Howard Robert Horvitz, Mario Sznol, Caterina Strambio‐De‐Castillia, Laird Bloom, Günter Blobel, Pamela J. Vanderzalm, Gian Garriga and Jonathan Zalevsky. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Cancer Discovery, Current Oncology Reports, Clinical Genitourinary Cancer and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.